D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment
Background: Animal and postmortem studies indicate that neuroleptic therapy may induce D2 dopamine receptor up-regulation in the basal ganglia. Methods: To address this phenomenon in a clinical study, we investigated the D2 dopamine receptor binding in 15 DSM-III-R schizophrenics in the drug-naive s...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 July 1998
|
| In: |
Biological psychiatry
Year: 1998, Jahrgang: 43, Heft: 9, Pages: 660-665 |
| ISSN: | 1873-2402 |
| DOI: | 10.1016/S0006-3223(97)00442-3 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0006-3223(97)00442-3 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0006322397004423 |
| Verfasserangaben: | Johannes Schröder, Simone Silvestri, Bernd Bubeck, Markus Karr, Sibylle Demisch, Sabine Scherrer, Franz J Geider, Heinrich Sauer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1745625097 | ||
| 003 | DE-627 | ||
| 005 | 20230426064714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210126s1998 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0006-3223(97)00442-3 |2 doi | |
| 035 | |a (DE-627)1745625097 | ||
| 035 | |a (DE-599)KXP1745625097 | ||
| 035 | |a (OCoLC)1341389306 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schröder, Johannes |d 1957- |e VerfasserIn |0 (DE-588)138708517 |0 (DE-627)605263469 |0 (DE-576)308769848 |4 aut | |
| 245 | 1 | 0 | |a D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia |b a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment |c Johannes Schröder, Simone Silvestri, Bernd Bubeck, Markus Karr, Sibylle Demisch, Sabine Scherrer, Franz J Geider, Heinrich Sauer |
| 264 | 1 | |c 20 July 1998 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.01.2021 | ||
| 520 | |a Background: Animal and postmortem studies indicate that neuroleptic therapy may induce D2 dopamine receptor up-regulation in the basal ganglia. Methods: To address this phenomenon in a clinical study, we investigated the D2 dopamine receptor binding in 15 DSM-III-R schizophrenics in the drug-naive state and 3 days after completion of a standardized neuroleptic therapy (benperidol 12-16 mg/day, for 25 days) using single photon emission computed tomography (SPECT). SPECT scans were obtained 2 hours after intravenous injection of 185 MBq 123I-iodobenzamide. For analysis, basal ganglia to frontal cortex (BG/FC) ratios were calculated and the patient sample was subgrouped into patients with a favorable versus a poor treatment response. Results: Neuroleptic treatment led to decreased BG/FC ratios in patients with a favorable response, but increased ratios in the poor responders (df = 1, F = 4.1, p = .06). Changes of BG/FC ratios were significantly correlated with extrapyramidal side effects but not with neurological soft signs. Conclusions: Our findings suggest that neuroleptic therapy may induce D2 dopamine receptor up-regulation in a subgroup of patients characterized by poor treatment response and pronounced extrapyramidal side effects. | ||
| 650 | 4 | |a D dopamine receptor up-regulation | |
| 650 | 4 | |a extrapyramidal side effects | |
| 650 | 4 | |a neurological soft signs | |
| 650 | 4 | |a Schizophrenia | |
| 650 | 4 | |a single photon emission computed tomography | |
| 650 | 4 | |a treatment response | |
| 700 | 1 | |a Fauth Silvestri, Simone |d 1962- |e VerfasserIn |0 (DE-588)118008013 |0 (DE-627)694590029 |0 (DE-576)291665519 |4 aut | |
| 700 | 1 | |a Bubeck, Bernd |d 1949- |e VerfasserIn |0 (DE-588)1067692207 |0 (DE-627)819091502 |0 (DE-576)426855493 |4 aut | |
| 700 | 1 | |a Karr, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Demisch, Sibylle |e VerfasserIn |0 (DE-588)1121608310 |0 (DE-627)874376858 |0 (DE-576)176413200 |4 aut | |
| 700 | 1 | |a Scherrer, Sabine |e VerfasserIn |0 (DE-588)1138800279 |0 (DE-627)896384209 |0 (DE-576)168357119 |4 aut | |
| 700 | 1 | |a Geider, Franz Josef |e VerfasserIn |0 (DE-588)172112796 |0 (DE-627)697025292 |0 (DE-576)132985594 |4 aut | |
| 700 | 1 | |a Sauer, Heinrich |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biological psychiatry |d Amsterdam [u.a.] : Elsevier Science, 1985 |g 43(1998), 9, Seite 660-665 |h Online-Ressource |w (DE-627)306654296 |w (DE-600)1499907-9 |w (DE-576)115780807 |x 1873-2402 |7 nnas |a D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment |
| 773 | 1 | 8 | |g volume:43 |g year:1998 |g number:9 |g pages:660-665 |g extent:6 |a D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0006-3223(97)00442-3 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0006322397004423 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210126 | ||
| 993 | |a Article | ||
| 994 | |a 1998 | ||
| 998 | |g 1067692207 |a Bubeck, Bernd |m 1067692207:Bubeck, Bernd |d 50000 |e 50000PB1067692207 |k 0/50000/ |p 3 | ||
| 998 | |g 138708517 |a Schröder, Johannes |m 138708517:Schröder, Johannes |d 910000 |d 910600 |e 910000PS138708517 |e 910600PS138708517 |k 0/910000/ |k 1/910000/910600/ |p 1 |x j | ||
| 999 | |a KXP-PPN1745625097 |e 384237948X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia","subtitle":"a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment","title_sort":"D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia"}],"person":[{"family":"Schröder","role":"aut","given":"Johannes","display":"Schröder, Johannes"},{"given":"Simone","role":"aut","display":"Fauth Silvestri, Simone","family":"Fauth Silvestri"},{"family":"Bubeck","display":"Bubeck, Bernd","role":"aut","given":"Bernd"},{"display":"Karr, Markus","given":"Markus","role":"aut","family":"Karr"},{"display":"Demisch, Sibylle","given":"Sibylle","role":"aut","family":"Demisch"},{"given":"Sabine","role":"aut","display":"Scherrer, Sabine","family":"Scherrer"},{"family":"Geider","role":"aut","given":"Franz Josef","display":"Geider, Franz Josef"},{"display":"Sauer, Heinrich","role":"aut","given":"Heinrich","family":"Sauer"}],"name":{"displayForm":["Johannes Schröder, Simone Silvestri, Bernd Bubeck, Markus Karr, Sibylle Demisch, Sabine Scherrer, Franz J Geider, Heinrich Sauer"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"306654296","origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1985","dateIssuedDisp":"1985-","publisher":"Elsevier Science"}],"note":["Gesehen am 08.01.20","Ungezählte Beil.: Supplement"],"disp":"D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia a follow-up study with 123I-Iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatmentBiological psychiatry","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306654296"],"issn":["1873-2402"],"zdb":["1499907-9"]},"pubHistory":["Nachgewiesen 20.1985 -"],"part":{"volume":"43","year":"1998","text":"43(1998), 9, Seite 660-665","extent":"6","pages":"660-665","issue":"9"},"language":["eng"],"title":[{"title_sort":"Biological psychiatry","title":"Biological psychiatry","subtitle":"a journal of psychiatric neuroscience ; a publication of the Society of Biological Psychiatry"}]}],"note":["Gesehen am 26.01.2021"],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1745625097"],"doi":["10.1016/S0006-3223(97)00442-3"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1745625097","origin":[{"dateIssuedDisp":"20 July 1998","dateIssuedKey":"1998"}]} | ||
| SRT | |a SCHROEDERJD2DOPAMINE2019 | ||